Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Trends in Prevalence of Blindness and Distance and Near Vision Impairment Over 30 Years: An Analysis for the Global Burden of Disease Study Publisher Pubmed



Bourne RRA1 ; Steinmetz JD3 ; Flaxman S7 ; Briant PS1 ; Taylor HR10 ; Resnikoff S11, 12 ; Casson RJ13 ; Abdoli A14 ; Abugharbieh E15 ; Afshin A3, 4 ; Ahmadieh H16, 17 ; Akalu Y20 ; Alamneh AA22 ; Alemayehu W23, 24 Show All Authors
Authors
  1. Bourne RRA1
  2. Steinmetz JD3
  3. Flaxman S7
  4. Briant PS1
  5. Taylor HR10
  6. Resnikoff S11, 12
  7. Casson RJ13
  8. Abdoli A14
  9. Abugharbieh E15
  10. Afshin A3, 4
  11. Ahmadieh H16, 17
  12. Akalu Y20
  13. Alamneh AA22
  14. Alemayehu W23, 24
  15. Alfaar AS25, 26
  16. Alipour V27, 28
  17. Anbesu EW31
  18. Androudi S32
  19. Arabloo J27
  20. Arditi A33
  21. Asaad M34
  22. Bagli E35, 36
  23. Baig AA37
  24. Barnighausen TW38, 40
  25. Parodi MB42
  26. Bhagavathula AS43, 44
  27. Bhardwaj N45
  28. Bhardwaj P46, 47
  29. Bhattacharyya K48, 49
  30. Bijani A50
  31. Bikbov M51
  32. Bottone M7, 52
  33. Braithwaite T53, 54
  34. Bron AM55, 56
  35. Butt ZA57, 58
  36. Cheng CY59, 60
  37. Chu DT61
  38. Cicinelli MV62
  39. Coelho JM63
  40. Dagnew B21
  41. Dai X3
  42. Dana R41
  43. Dandona L3, 64, 65
  44. Dandona R3, 4, 64
  45. Del Monte MA66
  46. Deva JP68
  47. Diaz D69, 70
  48. Djalalinia S71
  49. Dreer LE72
  50. Ehrlich JR66, 67
  51. Ellwein LB74
  52. Emamian MH75
  53. Fernandes AG76
  54. Fischer F77
  55. Friedman DS41
  56. Furtado JM78
  57. Gaidhane AM79
  58. Gaidhane S82
  59. Gazzard G83
  60. Gebremichael B84
  61. George R85
  62. Ghashghaee A27, 29
  63. Golechha M86
  64. Hamidi S88
  65. Hammond BR89
  66. Hartnett MER90
  67. Hartono RK91
  68. Hay SI3, 4
  69. Heidari G92
  70. Ho HC93
  71. Hoang CL94
  72. Househ M95
  73. Ibitoye SE96
  74. Ilic IM97
  75. Ilic MD98
  76. Ingram AD99
  77. Irvani SSN18
  78. Jha RP100, 101
  79. Kahloun R102
  80. Kandel H103, 104
  81. Kasa AS105
  82. Kempen JH41, 106
  83. Keramati M107
  84. Khairallah M109
  85. Khan EA110
  86. Khanna RC11, 111
  87. Khatib MN80
  88. Kim JE112
  89. Kim YJ113
  90. Kisa A114, 115
  91. Kisa S116
  92. Koyanagi A117, 118
  93. Kurmi OP119, 121
  94. Lansingh VC122, 123
  95. Leasher JL124
  96. Leveziel N125, 126
  97. Limburg H127
  98. Majdan M128
  99. Manafi N30, 129
  100. Mansouri K130, 131
  101. Mcalinden C132
  102. Mohammadi SF133
  103. Mohammadianhafshejani A134
  104. Mohammadpourhodki R107
  105. Mokdad AH3, 4
  106. Moosavi D135
  107. Morse AR136, 137
  108. Naderi M138
  109. Naidoo KS11, 139
  110. Nangia V140
  111. Nguyen CT141
  112. Nguyen HLT141
  113. Ogundimu K142
  114. Olagunju AT120, 121, 143
  115. Ostroff SM3, 5
  116. Pandajones S39
  117. Pesudovs K11
  118. Peto T144
  119. Syed ZQ79
  120. Ur Rahman MH145
  121. Ramulu PY146
  122. Rawaf DL8, 148
  123. Rawaf S9, 149
  124. Reinig N3
  125. Robin AL147, 150
  126. Rossetti L151
  127. Safi S16, 19
  128. Sahebkar A108, 152
  129. Samy AM153
  130. Saxena D79, 87
  131. Serle JB154
  132. Shaikh MA155
  133. Shen TT6
  134. Shibuya K156
  135. Shin JI157
  136. Silva JC158
  137. Silvester A2, 159
  138. Singh JA73, 160
  139. Singhal D81, 161
  140. Sitorus RS162, 163
  141. Skiadaresi E164
  142. Skirbekk V165
  143. Soheili A166
  144. Sousa RARC167
  145. Spurlock EE3
  146. Stambolian D168
  147. Taddele BW169
  148. Tadesse EG170
  149. Tahhan N11
  150. Tareque MDI171
  151. Topouzis F172
  152. Tran BX173
  153. Travillian RS3
  154. Tsilimbaris MK174
  155. Varma R175
  156. Virgili G144, 176
  157. Wang N177
  158. Wang YX178
  159. West SK146
  160. Wong TY1, 179
  161. Zaidi Z180
  162. Zewdie KA181
  163. Jonas JB2, 178
  164. Vos T3, 4

Source: The Lancet Global Health Published:2021


Abstract

Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of global vision impairment in 2020 and temporal change is needed. We aimed to extensively update estimates of global vision loss burden, presenting estimates for 2020, temporal change over three decades between 1990–2020, and forecasts for 2050. Methods: We did a systematic review and meta-analysis of population-based surveys of eye disease from January, 1980, to October, 2018. Only studies with samples representative of the population and with clearly defined visual acuity testing protocols were included. We fitted hierarchical models to estimate 2020 prevalence (with 95% uncertainty intervals [UIs]) of mild vision impairment (presenting visual acuity ≥6/18 and <6/12), moderate and severe vision impairment (<6/18 to 3/60), and blindness (<3/60 or less than 10° visual field around central fixation); and vision impairment from uncorrected presbyopia (presenting near vision
Other Related Docs
10. Outcomes of Cataract Surgery at a Referral Center, Journal of Ophthalmic and Vision Research (2015)